NLS Pharmaceutics Enters Definitive Merger Agreement With Kadimastem; At Closing, NLS Will Issue Shares Of Its Common Stock To Kadimastem's Shareholders Based On An Initial Target Fully Diluted Share Split, Post Transaction, Of 85% To Kadimastem...

Benzinga · Nov 4 20:07

NLS Pharmaceutics Enters Definitive Merger Agreement With Kadimastem; At Closing, NLS Will Issue Shares Of Its Common Stock To Kadimastem's Shareholders Based On An Initial Target Fully Diluted Share Split, Post Transaction, Of 85% To Kadimastem Stakeholders And 15% To Nls Stakeholders, In Exchange For 100% Of Kadimastem's Issued And Outstanding Shares

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

NLS Pharmaceutics Enters Definitive Merger Agreement With Kadimastem; At Closing, NLS Will Issue Shares Of Its Common Stock To Kadimastem's Shareholders Based On An Initial Target Fully Diluted Share Split, Post Transaction, Of 85% To Kadimastem...

Risk Disclaimer